After activation of the cGAS-STING pathways, type I interferon production is instrumental in DC maturation and its cross-presentation of tumor antigens (TAs) to antigen-specific CD8+ T cells, which exerts adaptive antitumor immunity [28, 29]. This evidence concerns the gene STING1 and neoplasm.